Can Zepbound, Ozempic, Wegovy or Mounjaro Cause a Rash? Itching, Hives and Skin Pain Explained
Rash, itching and hives on Zepbound, Ozempic, Wegovy or Mounjaro: label rates, injection-site vs allergic reactions, skin pain, warning signs, user stories.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
Yes, it can happen, but it is uncommon. Skin reactions on GLP-1 drugs come in three kinds: redness, itching or a rash where the pen went in (injection-site reactions); an allergic reaction that can spread over the body (hives, itching, rash); and, less often, skin that burns, tingles or hurts with nothing visible (dysesthesia — covered on GLP-1 skin changes). In the Zepbound weight-loss trials, hypersensitivity reactions were reported in about 5% of people vs 3% on placebo, and most were skin reactions such as rash or itching. Swelling of the face, lips, tongue or throat, trouble breathing or fainting is an emergency. Not medical advice. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance. Last reviewed November 6, 2026.
What the US labels report
| Drug | Skin and allergic reactions in trials |
|---|---|
| Zepbound | Hypersensitivity 5% vs 3% placebo, mostly skin reactions such as rash and itching; immediate reactions 2.1% vs 0.4%. Injection-site reactions (redness, itching, pain, rash, bruising) 6 to 8% vs 2%. Anaphylaxis and angioedema reported after approval |
| Mounjaro | Hypersensitivity 3.2% vs 1.7%, sometimes severe (e.g. hives and eczema). Injection-site reactions 3.2% vs 0.4%. Anaphylaxis and angioedema reported after approval |
| Wegovy | Injection-site reactions 1.4% vs 1% (itching, redness, swelling, hardening). Teen trial: rash 3% and hives 3% vs 0%. Higher-dose trial: skin-sensation changes (burning, tingling, skin pain, sensitive skin) in 22% vs 0% on placebo, and 6% on the standard dose. Rash, hives, anaphylaxis and angioedema reported after approval |
| Ozempic | Injection-site reactions 0.2% (discomfort, redness). Rash, hives, anaphylaxis and angioedema reported after approval |
Injection-site reaction or allergy?
Both Zepbound and Mounjaro labels note that reactions were more frequent in people who developed antibodies to tirzepatide. More on the local kind: Ozempic injection site reactions.
| Injection-site reaction | Allergic (hypersensitivity) reaction | |
|---|---|---|
| Where | Only around the spot the pen was used | Can be anywhere: hives or a rash on the trunk, arms or face |
| Looks like | Redness, itching, a small lump or bruise | Raised itchy welts, widespread rash, flushing; sometimes swelling |
| Timing | Hours to a few days after a shot | Within a day (immediate) or later; can appear after several uneventful weeks |
| Usual course | Mild and short-lived in most reports | Needs a prescriber's review; serious reactions mean stopping the drug |
Skin that burns or hurts with no rash
Burning, tingling or skin pain with nothing visible (dysesthesia), plus dry or crepey skin after rapid weight loss, are covered on GLP-1 skin changes — not on this rash page.
When to get help
- —Call emergency services for swelling of the face, lips, tongue or throat, trouble breathing or swallowing, a racing heart with faintness, or a severe rash that spreads quickly. All four labels say not to use the drug after a serious allergic reaction to it.
- —See your prescriber promptly for hives or a body-wide rash, a rash with fever or blisters, or itching that keeps coming back after each shot.
- —An injection-site area that grows, turns hot, oozes or hurts more each day can be infected and needs to be looked at.
- —Don't take someone else's advice on antihistamines or creams over your prescriber's or pharmacist's.
What users report here
From live confessions (checked October 30, 2026). #688 says semaglutide, tirzepatide and retatrutide all gave them flushing, itching and hives, so they can't use any of them. #701 got red, itchy bumps at the injection site that lasted days after three uneventful months on retatrutide. #844 noticed red, itchy bumps all over the body, not just at the injection site, two days after a second retatrutide shot. #289 describes skin that felt like it was on fire, with pins and needles and nothing visible, on retatrutide. Stories, not rates, and retatrutide reports involve unapproved products.
Related topics
related peptides:
in Canada:
community guides:
More confessions from the archive
Community Q&A
- Does Zepbound cause a rash?
- It can. In the Zepbound weight-loss trials, hypersensitivity reactions were reported in about 5% of people vs 3% on placebo, and most were skin reactions such as rash or itching. Injection-site reactions, including redness, itching and rash at the site, were reported in 6 to 8%.
- Does Ozempic cause a rash?
- Rash and hives are listed among reactions reported after approval, and injection-site reactions were reported in 0.2% of people in Ozempic trials. Serious allergic reactions are rare but possible.
- Why do I itch after my Mounjaro or Zepbound shot?
- Itching around the spot is usually an injection-site reaction. Itching or hives elsewhere on the body can be an allergic reaction and should be reported to your prescriber.
- Why does my skin hurt on Wegovy?
- The Wegovy label reports skin-sensation changes such as burning, tingling or skin pain (dysesthesia), more often on the higher-dose option. See the GLP-1 skin changes page for details, and tell your prescriber if it happens.
- When is a GLP-1 rash an emergency?
- Swelling of the face, lips, tongue or throat, trouble breathing, fainting or a fast-spreading severe rash. Call emergency services.
- Does this page give dosing advice?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Sources
Last reviewed November 6, 2026. Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.